Literature DB >> 28282534

Clinical presentation of Attenuated Psychosis Syndrome in children and adolescents: Is there an age effect?

Michele Ribolsi1, Ashleigh Lin2, Klaas J Wardenaar3, Maria Pontillo1, Luigi Mazzone1, Stefano Vicari1, Marco Armando4.   

Abstract

There is limited research on clinical features related to age of presentation of the Attenuated Psychosis Syndrome in children and adolescents (CAD). Based on findings in CAD with psychosis, we hypothesized that an older age at presentation of Attenuated Psychosis Syndrome would be associated with less severe symptoms and better psychosocial functioning than presentation in childhood or younger adolescence. Ninety-four CAD (age 9-18) meeting Attenuated Psychosis Syndrome criteria participated in the study. The sample was divided and compared according to the age of presentation of Attenuated Psychosis Syndrome (9-14 vs 15-18 years). The predictive value of age of Attenuated Psychosis Syndrome presentation was investigated using receiver operating characteristic (ROC)-curve calculations. The two Attenuated Psychosis Syndrome groups were homogeneous in terms of gender distribution, IQ scores and comorbid diagnoses. Older Attenuated Psychosis Syndrome patients showed better functioning and lower depressive scores. ROC curves revealed that severity of functional impairment was best predicted using an age of presentation cut-off of 14.9 years for social functioning and 15.9 years for role functioning. This study partially confirmed our hypothesis; older age at presentation of Attenuated Psychosis Syndrome was associated with less functional impairment, but age was not associated with psychotic symptoms.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adolescents; Attenuated psychosis syndrome; Children; Functioning; Psychosocial; Psychotic symptoms; Ultra high risk

Mesh:

Year:  2017        PMID: 28282534     DOI: 10.1016/j.psychres.2017.02.050

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  6 in total

1.  Effects of age and sex on clinical high-risk for psychosis in the community.

Authors:  Frauke Schultze-Lutter; Benno G Schimmelmann; Rahel Flückiger; Chantal Michel
Journal:  World J Psychiatry       Date:  2020-05-19

2.  Spontaneous discontinuation of distressing auditory verbal hallucinations in a school-based sample of adolescents: a longitudinal study.

Authors:  Vera Brink; Catheleine van Driel; Saliha El Bouhaddani; Klaas J Wardenaar; Lieke van Domburgh; Barbara Schaefer; Marije van Beilen; Agna A Bartels-Velthuis; Wim Veling
Journal:  Eur Child Adolesc Psychiatry       Date:  2019-08-27       Impact factor: 4.785

3.  Auditory Mismatch Negativity in Youth Affected by Autism Spectrum Disorder With and Without Attenuated Psychosis Syndrome.

Authors:  Giorgio Di Lorenzo; Assia Riccioni; Michele Ribolsi; Martina Siracusano; Paolo Curatolo; Luigi Mazzone
Journal:  Front Psychiatry       Date:  2020-11-24       Impact factor: 4.157

4.  Clinical profile and conversion rate to full psychosis in a prospective cohort study of youth affected by autism spectrum disorder and attenuated psychosis syndrome: A preliminary report.

Authors:  Assia Riccioni; Martina Siracusano; Michelangelo Vasta; Michele Ribolsi; Federico Fiori Nastro; Leonardo Emberti Gialloreti; Giorgio Di Lorenzo; Luigi Mazzone
Journal:  Front Psychiatry       Date:  2022-09-23       Impact factor: 5.435

5.  DSM-5 Attenuated Psychosis Syndrome in Adolescents Hospitalized With Non-psychotic Psychiatric Disorders.

Authors:  Gonzalo Salazar de Pablo; Daniel Guinart; Barbara A Cornblatt; Andrea M Auther; Ricardo E Carrión; Maren Carbon; Sara Jiménez-Fernández; Ditte L Vernal; Susanne Walitza; Miriam Gerstenberg; Riccardo Saba; Nella Lo Cascio; Martina Brandizzi; Celso Arango; Carmen Moreno; Anna Van Meter; Paolo Fusar-Poli; Christoph U Correll
Journal:  Front Psychiatry       Date:  2020-10-21       Impact factor: 4.157

6.  Autism Spectrum Disorder and Clinical High Risk for Psychosis: A Systematic Review and Meta-analysis.

Authors:  Julio Vaquerizo-Serrano; Gonzalo Salazar de Pablo; Jatinder Singh; Paramala Santosh
Journal:  J Autism Dev Disord       Date:  2021-05-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.